BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11289474)

  • 1. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy.
    Bosman DR; Winkler AS; Marsden JT; Macdougall IC; Watkins PJ
    Diabetes Care; 2001 Mar; 24(3):495-9. PubMed ID: 11289474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure.
    Bosman DR; Osborne CA; Marsden JT; Macdougall IC; Gardner WN; Watkins PJ
    Diabet Med; 2002 Jan; 19(1):65-9. PubMed ID: 11869305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted erythropoietin response to anemia in patients with Type 1 diabetes.
    Cotroneo P; Maria Ricerca B; Todaro L; Pitocco D; Manto A; Ruotolo V; Storti S; Damiani P; Caputo S; Ghirlanda G
    Diabetes Metab Res Rev; 2000; 16(3):172-6. PubMed ID: 10867716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin depletion and anaemia in diabetes mellitus.
    Winkler AS; Marsden J; Chaudhuri KR; Hambley H; Watkins PJ
    Diabet Med; 1999 Oct; 16(10):813-9. PubMed ID: 10547207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin response to anemia and its association with autonomic neuropathy in type 2 diabetic patients without advanced renal failure.
    Kim MK; Baek KH; Lim DJ; Kim YK; Kang MI; Lee KW; Song KH
    J Diabetes Complications; 2010; 24(2):90-5. PubMed ID: 19303331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.
    Fujita Y; Doi Y; Hamano T; Hatazaki M; Umayahara Y; Isaka Y; Tsubakihara Y
    Sci Rep; 2019 Oct; 9(1):14871. PubMed ID: 31619722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathy.
    Yun YS; Lee HC; Yoo NC; Song YD; Lim SK; Kim KR; Hahn JS; Huh KB
    Diabetes Res Clin Pract; 1999 Dec; 46(3):223-9. PubMed ID: 10624788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia with impaired erythropoietin response in diabetic patients.
    Thomas MC; Cooper ME; Tsalamandris C; MacIsaac R; Jerums G
    Arch Intern Med; 2005 Feb; 165(4):466-9. PubMed ID: 15738380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum erythropoietin concentrations in patients with anemia--preliminary hemoglobin-related reference ranges.
    Vogeser M; Schiel X
    Clin Lab; 2002; 48(11-12):595-8. PubMed ID: 12465743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia.
    Thomas MC; Tsalamandris C; Macisaac R; Jerums G
    Diabet Med; 2006 May; 23(5):502-9. PubMed ID: 16681558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients?
    Spallone V; Maiello MR; Kurukulasuriya N; Barini A; Lovecchio M; Tartaglione R; Mennuni G; Menzinger G
    Diabet Med; 2004 Nov; 21(11):1174-80. PubMed ID: 15498082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia and diabetes in the absence of nephropathy.
    Craig KJ; Williams JD; Riley SG; Smith H; Owens DR; Worthing D; Cavill I; Phillips AO
    Diabetes Care; 2005 May; 28(5):1118-23. PubMed ID: 15855576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coefficient of variation of R-R intervals in electrocardiogram is a sensitive marker of anemia induced by autonomic neuropathy in type 1 diabetes.
    Saito T; Tojo K; Nishimura R; Kageyama S; Tajima N
    Diabetes Res Clin Pract; 2007 Oct; 78(1):60-4. PubMed ID: 17481773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin requirement in patients with type 2 diabetes mellitus on maintenance hemodialysis therapy.
    Biesenbach G; Schmekal B; Eichbauer-Sturm G; Janko O
    Wien Klin Wochenschr; 2004 Dec; 116(24):844-8. PubMed ID: 15690969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.
    Kuriyama S; Tomonari H; Yoshida H; Hashimoto T; Kawaguchi Y; Sakai O
    Nephron; 1997; 77(2):176-85. PubMed ID: 9346384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing and determinants of erythropoietin deficiency in chronic kidney disease.
    Mercadal L; Metzger M; Casadevall N; Haymann JP; Karras A; Boffa JJ; Flamant M; Vrtovsnik F; Stengel B; Froissart M;
    Clin J Am Soc Nephrol; 2012 Jan; 7(1):35-42. PubMed ID: 22096037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anemia in diabetic nephropathy: prevalence, clinical and pathophysiological aspects].
    Shestakova MV; Martynov SA; Il'in AV; Kniazeva AP; Shamkhalova MSh; Trubitsyna NP
    Ter Arkh; 2008; 80(6):41-7. PubMed ID: 18655475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum erythropoietin levels may be inappropriately low in the acute neuropsychiatric porphyrias.
    Winkler AS; Marsden J; Deacon A; Wilson S; Chandler G; Macdougall IC; Peters TJ
    Clin Chim Acta; 2002 Mar; 317(1-2):93-100. PubMed ID: 11814463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy.
    Inomata S; Itoh M; Imai H; Sato T
    Nephron; 1997; 75(4):426-30. PubMed ID: 9127329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced erythropoietin secretion in senile anemia.
    Kario K; Matsuo T; Kodama K; Nakao K; Asada R
    Am J Hematol; 1992 Dec; 41(4):252-7. PubMed ID: 1288287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.